Filing Details
- Accession Number:
- 0001225208-13-024752
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2013-12-04 17:28:32
- Reporting Period:
- 2013-11-08
- Filing Date:
- 2013-12-04
- Accepted Time:
- 2013-12-04 17:28:32
- Original Submission Date:
- 2013-11-12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1566094 | B. Jeffrey Mirviss | One Boston Scientific Place Natick MA 01760-1537 | Svp&Pres, Periph Intervent | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-11-08 | 20,000 | $6.31 | 85,190 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-08 | 20,000 | $11.87 | 65,190 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-11-11 | 6,000 | $12.02 | 59,190 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-08 | 20,000 | $0.00 | 20,000 | $6.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 60,000 | 2020-10-25 | No | 4 | M | Direct |
Footnotes
- This amended Form 4 is being filed to report the stock option exercise that was omitted from the reporting person's Form 4 filed on November 12, 2013 and to correct the number of securities beneficially owned by the reporting person following the sale transactions on each of November 8, 2013 and November 11, 2013 as previously reported in the Form 4 filed on November 12, 2013 (see also Footnote 2).
- Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- Sale transaction was previously reported on the reporting person's Form 4 filed on November 12, 2013.
- Represents the weighted average sale price. These shares were sold in multiple transactions at $11.8700 and $11.8710. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price. These shares were sold in multiple transactions at $12.0202 and $12.0220. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Grant to reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on October 25, 2011, the first anniversary of the date of grant.
Billionaire Hedge Funds
